Skip to main content

Russell Alan J's Form 4 filing

Edgewise Therapeutics, Inc. (EWTX) · filed Feb 7, 2025

Accession no.
0001562180-25-001026
Filed
Feb 7, 2025, 4:38 PM ET
Trade date
Feb 5-6, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $276.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Russell Alan JCIK 0001853529Director, Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 5, 2025Common StockMOption exerciseAcquired+8,015$0.18+$1,442.722,878Direct
Feb 5, 2025Common StockSSaleDisposed−8,015$30.02−$240,623.1214,863Direct
Feb 6, 2025Common StockMOption exerciseAcquired+1,200$0.18+$21616,063Direct
Feb 6, 2025Common StockSSaleDisposed−1,200$30.13−$36,15314,863Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 5, 2025Common StockMOption exerciseDisposed−8,015$0.00$01,348,765Direct
Feb 6, 2025Common StockMOption exerciseDisposed−1,200$0.00$01,347,565Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)